Proteomics profiling of kidney brush border membrane from rats using LC‐MS/MS analysis

• Published in: Proteomics. Clinical applications Vol. 17; no. 2; pp. e2200063 - n/a
• Main Authors: Yu, Aiying, Zhao, Jingfu, Peng, Wenjing, Yadav, Shiv Pratap S., Molitoris, Bruce A, Wagner, Mark C, Mechref, Yehia
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.03.2023
• Subjects: Albuminuria - complications; Albuminuria - diagnosis; Animal models; Animals; brush border membrane; Brush border membranes; Chromatography, Liquid; chronic kidney disease; Creatinine; Damage assessment; Design of experiments; Glomerular filtration rate; Humans; Intercellular adhesion molecule 1; Kidney - metabolism; Kidney diseases; LC‐MS/MS; Membranes; Microvilli; pathway; protein abundance; Proteins; Proteinuria; Proteomics; proteomics proteinuria and hypertension; Rats; Renal function; Renal Insufficiency, Chronic; Signal transduction; Tandem Mass Spectrometry; Urination; Wnt protein; LC-MS/MS; pathway; chronic kidney disease; proteomics proteinuria and hypertension; protein abundance; brush border membrane
• ISSN: 1862-8346; 1862-8354
• DOI: 10.1002/prca.202200063

Purpose Chronic kidney disease (CKD) is defined by a reduced renal function, that is, glomerular filtration rate, and the extent of kidney damage is assessed by determining serum creatinine levels and proteins in urine, diagnosed as proteinuria/albuminuria. Albuminuria increases with age and can result from glomerular and/or proximal tubule (PT) alterations. Brush border membranes (BBMs) on PT cells are important in maintaining the stability of PT functions. Experimental Design An LC‐MS/MS bottom‐up proteomics analysis of BBMs from four groups of rat models was applied to investigate protein abundance alterations associated with CKD progression. Moreover, systems biology analyses were used to identify key proteins that can provide insight into the different regulated molecular pathways and processes associated with CKD. Results Our results indicated that 303 proteins showed significantly altered expressions from the severe CKD BBM group when compared to the control. Focusing on renal diseases, several proteins including Ctnnb1, Fah, and Icam1 were annotated to kidney damage and urination disorder. The up‐regulation of Ctnnb1 (β‐catenin) could contribute to CKD through the regulation of the WNT signaling pathway. Conclusion and Clinical Relevance Overall, the study of protein abundance changes in BBMs from rat models helps to reveal protein corrections with important pathways and regulator effects involved in CKD. Although this study is focused on rat models, the results provided more information for a deeper insight into possible CKD mechanisms in humans.